Ask AI

Wake Up to Cardiovascular Risk: Managing Narcolepsy and Idiopathic Hypersomnia Beyond Sleep

Patients with narcolepsy or idiopathic hypersomnia are at increased cardiovascular risk, and some medications used to treat these conditions may further elevate that risk. Learn about the pathophysiologic mechanisms underlying cardiovascular risk in these sleep disorders, current evidence-based recommendations to help minimize that risk, and strategies to individualize treatment plans incorporating risk management alongside symptom control.

Share

Program Content

Activities

Narcolepsy and Idiopathic Hypersomnia
Why Are Patients With Narcolepsy and Idiopathic Hypersomnia at Increased Cardiovascular Risk?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2025

Expires: July 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.